Aarti Drugs said that its board has approved the re-appointed of Rashesh C. Gogri as the managing directors (MD) of the company with effect from 31 October 2022 for the period of five years.
The said appointment is subject to approval of the shareholders of the company.
Rashesh C. Gogri had been president - marketing with the company and then after appointed as the managing director of the company in the year 2012. He has more than 20 years of experience in the field of production, marketing and project implementation in the chemical and pharmaceuticals industry.
Aarti Drugs is primarily involved in manufacturing and marketing of active pharmaceutical ingredients (API), pharma intermediates and specialty chemicals.
On a consolidated basis, net profit of Aarti Drugs declined 28.72% to Rs 34.79 crore on 7.24% rise in net sales to Rs 621.96 crore in Q1 June 2022 over Q1 June 2021.
The scrip shed 0.58% to currently trade at Rs 443.90 on the BSE.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app